Convatec Group (LSE:CTEC) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:CTEC Convatec Group PLC LSE:CTEC
77 GF Score
Price £2.11
GF Value £2.56
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Convatec Group Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LSE:CTEC
77GF Score
Convatec Group PLC LSE:CTEC
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Convatec Group (LSE:CTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of £2.11 is trading 17.7% below its estimated GF Value™ of £2.56. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for LSE:CTEC:

  • Short Ratio:
  • GF Value™: £2.56 vs. price of £2.11 (17.7% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the LSE:CTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for LSE:CTEC

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.11
Price
£2.56
GF Value